|
Q2 2025
|
17 |
520,168 |
I9SA.HA, LQDA, EXEL, AGIO
|
13F-HR
|
8/14/2025 |
000142050625002188 |
|
Q1 2025
|
16 |
479,228 |
LQDA, I9SA.HA, EXEL, MLYS
|
13F-HR
|
5/15/2025 |
000142050625001290 |
|
Q4 2024
|
14 |
394,876 |
LQDA, I9SA.HA, EXEL, EOLS
|
13F-HR
|
2/14/2025 |
000142050625000624 |
|
Q3 2024
|
12 |
315,472 |
LQDA, I9SA.HA, EXEL, EOLS
|
13F-HR
|
11/14/2024 |
000142050624002574 |
|
Q2 2024
|
13 |
427,996 |
LQDA, ALIM, ANIK, EXEL
|
13F-HR
|
8/14/2024 |
000181455424000010 |
|
Q1 2024
|
12 |
378,314 |
LQDA, ALIM, ANIK, EOLS
|
13F-HR
|
5/13/2024 |
000172749224000006 |
|
Q4 2023
|
11 |
296,522 |
LQDA, ALIM, ANIK, EXEL
|
13F-HR
|
2/14/2024 |
000172749224000002 |
|
Q3 2023
|
13 |
217,755 |
LQDA, ALIM, INTERCEPT PHARMACEUTICALS INC puts, LAB
|
13F-HR
|
11/14/2023 |
000172749223000011 |
|
Q2 2023
|
13 |
177,813 |
LQDA, ANIK, EXEL, LAB
|
13F-HR
|
8/14/2023 |
000172749223000009 |
|
Q1 2023
|
11 |
143,374 |
LQDA, ANIK, LAB, EXEL
|
13F-HR
|
5/15/2023 |
000181455423000002 |
|
Q4 2022
|
11 |
120,160 |
LQDA, ANIK, EOLS, ADMA
|
RESTATEMENT
|
5/15/2023 |
000181455423000005 |